| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ODTX
Odyssey Therapeutics, Inc.
|
Jun 18, 2026 | BUY |
Strong Buy
+67.8% avg upside
5 analysts
|
— | · |
|
TVTX
Travere Therapeutics
|
Jun 02, 2026 | BUY |
Strong Buy
-16.0% avg upside
22 analysts
|
$60.00
8.70% Upside
|
+21.1% |
|
TYRA
Tyra Bioscience
|
May 13, 2026 | BUY |
Strong Buy
+57.9% avg upside
17 analysts
|
— | -19.7% |
|
ALLO
Allogene Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+662.1% avg upside
28 analysts
|
— | -18.4% |
|
ORKA
Oruka Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+61.8% avg upside
16 analysts
|
— | +12.2% |
|
ARVN
Arvinas Holding Company
|
May 12, 2026 | HOLD |
Strong Buy
+264.5% avg upside
27 analysts
|
— | -20.8% |
|
ZNTL
Zentalis Pharmaceuticals
|
May 12, 2026 | BUY |
Buy
+292.3% avg upside
16 analysts
|
— | -16.4% |
|
MAZE
Maze Therapeutics, Inc.
|
May 12, 2026 | BUY |
Strong Buy
+145.3% avg upside
12 analysts
|
— | -0.4% |
|
OLMA
Olema Pharmaceuticals
|
May 12, 2026 | BUY |
Strong Buy
+303.4% avg upside
16 analysts
|
— | -31.9% |
|
CCCC
C4 Therapeutics
|
May 12, 2026 | BUY |
Strong Buy
+330.3% avg upside
19 analysts
|
— | +12.3% |
|
IMNM
Immunome
|
May 12, 2026 | BUY |
Strong Buy
+82.7% avg upside
16 analysts
|
— | -18.3% |
|
CGON
CG Oncology, Inc.
|
May 11, 2026 | BUY |
Strong Buy
+41.1% avg upside
17 analysts
|
— | -11.9% |
|
AKTS
Aktis Oncology, Inc.
|
May 11, 2026 | BUY |
Strong Buy
+30.9% avg upside
8 analysts
|
— | · |
|
BCAX
Bicara Therapeutics Inc.
|
May 11, 2026 | BUY |
Strong Buy
+34.1% avg upside
14 analysts
|
— | +0.0% |
|
ARTV
Artiva Biotherapeutics, Inc.
|
May 11, 2026 | BUY |
Strong Buy
+239.4% avg upside
7 analysts
|
— | -2.5% |
|
APGE
Apogee Therapeutics
|
May 11, 2026 | BUY |
Strong Buy
+28.5% avg upside
19 analysts
|
— | +4.5% |
|
CRNX
Crinetics Pharmaceuticals
|
May 08, 2026 | BUY |
Strong Buy
+121.2% avg upside
20 analysts
|
— | -11.2% |
|
JBIO
Jade Biosciences
|
May 08, 2026 | BUY |
Strong Buy
+232.9% avg upside
16 analysts
|
— | -34.8% |
|
TECX
Tectonic Therapeutic
|
May 08, 2026 | BUY |
Strong Buy
+88.0% avg upside
24 analysts
|
— | -3.8% |
|
IOVA
Iovance Biotherapeutics
|
May 07, 2026 | BUY |
Strong Buy
+225.8% avg upside
24 analysts
|
$5.00
27.96% Upside
|
-2.8% |
|
MBX
MBX Biosciences, Inc.
|
May 07, 2026 | BUY |
Strong Buy
+53.4% avg upside
14 analysts
|
— | +15.5% |
|
NAMS
NewAmsterdam Pharma Company
|
May 07, 2026 | BUY |
Strong Buy
+56.4% avg upside
18 analysts
|
— | -14.4% |
|
ARQT
Arcutis Biotherapeutics
|
May 07, 2026 | BUY |
Strong Buy
+49.6% avg upside
14 analysts
|
$35.00
33.46% Upside
|
+24.2% |
|
BBIO
BridgeBio Pharma
|
May 07, 2026 | BUY |
Strong Buy
+38.7% avg upside
34 analysts
|
$95.00
43.42% Upside
|
-0.1% |
|
GILD
Gilead Sciences
|
May 07, 2026 | BUY |
Strong Buy
-4.8% avg upside
66 analysts
|
$160.00
29.25% Upside
|
-7.1% |
|
RNAC
Cartesian Therapeutics
|
May 06, 2026 | BUY |
Strong Buy
+228.2% avg upside
19 analysts
|
— | +6.8% |
|
IMCR
Immunocore Holdings
|
May 06, 2026 | BUY |
Strong Buy
+124.3% avg upside
22 analysts
|
$60.00
109.81% Upside
|
-8.7% |
|
SMMT
Summit Therapeutics
|
May 06, 2026 | BUY |
Strong Buy
+112.6% avg upside
27 analysts
|
— | -22.3% |
|
IDYA
IDEAYA Biosciences
|
May 05, 2026 | BUY |
Strong Buy
+55.2% avg upside
29 analysts
|
— | +8.5% |
|
SYRE
Spyre Therapeutics
|
May 05, 2026 | BUY |
Strong Buy
-15.4% avg upside
23 analysts
|
— | +17.7% |
|
CRSP
Crispr Therapeutics AG
|
May 04, 2026 | HOLD |
Buy
+39.1% avg upside
41 analysts
|
$45.00
16.90% Downside
|
+0.9% |
|
BHVN
Biohaven Ltd.
|
May 04, 2026 | BUY |
Strong Buy
+87.5% avg upside
25 analysts
|
$30.00
121.04% Upside
|
+33.8% |
|
MRNA
Moderna
|
May 01, 2026 | HOLD |
Hold
+6.1% avg upside
38 analysts
|
$40.00
37.48% Downside
|
+41.0% |
|
REGN
Regeneron
|
Apr 29, 2026 | BUY |
Strong Buy
+26.9% avg upside
57 analysts
|
$960.00
57.45% Upside
|
-11.3% |
|
EYPT
EyePoint Pharmaceuticals
|
Nov 05, 2025 | BUY |
Strong Buy
+123.7% avg upside
17 analysts
|
$20.00
47.30% Upside
|
+19.3% |
|
KROS
Keros Therapeutics
|
Nov 05, 2025 | HOLD |
Strong Buy
+139.0% avg upside
21 analysts
|
— | -32.9% |
|
RCKT
Rocket Pharmaceuticals
|
Aug 08, 2025 | HOLD |
Buy
+393.7% avg upside
29 analysts
|
— | +3.5% |
|
FATE
Fate Therapeutics
|
Nov 08, 2023 | HOLD |
Buy
+475.7% avg upside
31 analysts
|
— | +3.9% |
|
ALGS
Aligos Therapeutics
|
Mar 11, 2022 | BUY |
Strong Buy
+773.1% avg upside
11 analysts
|
$15.00
184.01% Upside
|
-49.0% |
|
TEVA
Teva Pharmaceutical
|
Oct 01, 2021 | HOLD |
Buy
-6.6% avg upside
39 analysts
|
— | -16.8% |
|
GYRE
Gyre Therapeutics
|
Oct 01, 2021 | HOLD |
Strong Buy
+212.0% avg upside
15 analysts
|
— | -53.1% |
|
NKTR
Nektar Therapeutics
|
Oct 01, 2021 | HOLD |
Strong Buy
+16.5% avg upside
25 analysts
|
— | -82.6% |
|
TSE:APS
Aptose Biosciences
|
Oct 01, 2021 | HOLD |
Strong Buy
+4065.6% avg upside
10 analysts
|
— | · |
|
INCY
Incyte
|
Oct 01, 2021 | HOLD |
Strong Buy
+1.0% avg upside
47 analysts
|
— | -2.3% |
|
GSK
GlaxoSmithKline
|
Oct 01, 2021 | HOLD |
Buy
-14.0% avg upside
19 analysts
|
— | -19.2% |
|
BCRX
BioCryst
|
Oct 01, 2021 | HOLD |
Strong Buy
+103.3% avg upside
24 analysts
|
— | -8.2% |
|
APOG
Apogee
|
Oct 01, 2021 | HOLD |
Strong Buy
+13.1% avg upside
7 analysts
|
— | +1.3% |
|
OCUL
Ocular Therapeutix
|
Oct 01, 2021 | HOLD |
Strong Buy
+160.4% avg upside
21 analysts
|
— | -60.0% |
|
PRAX
Praxis Precision Medicines
|
Oct 01, 2021 | HOLD |
Strong Buy
+91.5% avg upside
24 analysts
|
— | -88.2% |
|
NRIX
Nurix Therapeutics
|
Oct 01, 2021 | HOLD |
Strong Buy
+75.6% avg upside
26 analysts
|
— | -58.3% |
|
PLRX
Pliant Therapeutics
|
Oct 01, 2021 | HOLD |
Buy
+1821.1% avg upside
21 analysts
|
— | +21.0% |
|
GOSS
Gossamer Bio
|
Oct 01, 2021 | HOLD |
Buy
+4379.4% avg upside
17 analysts
|
— | -8.2% |
|
MGTX
Meiragtx Holdings
|
Oct 01, 2021 | HOLD |
Strong Buy
+130.4% avg upside
13 analysts
|
— | -36.8% |
|
AMRX
Amneal Pharmaceuticals
|
Oct 01, 2021 | HOLD |
Strong Buy
+5.6% avg upside
18 analysts
|
— | -63.5% |
|
OVID
Ovid Therapeutics
|
Oct 01, 2021 | HOLD |
Strong Buy
+109.1% avg upside
17 analysts
|
— | -47.9% |
|
CYPH
Cypherpunk Technologies
|
Oct 01, 2021 | HOLD |
Buy
+1087.0% avg upside
9 analysts
|
— | · |
|
ONC
BeOne Medicines
|
Oct 01, 2021 | HOLD |
Strong Buy
+28.4% avg upside
28 analysts
|
— | -62.2% |
|
IONS
Ionis Pharmaceuticals
|
Oct 01, 2021 | HOLD |
Strong Buy
+13.3% avg upside
43 analysts
|
— | +31.8% |
|
KURA
Kura Oncology
|
Oct 01, 2021 | HOLD |
Strong Buy
+161.3% avg upside
26 analysts
|
— | -28.6% |
|
TBPH
Theravance Biopharma
|
Oct 01, 2021 | HOLD |
Buy
+12.2% avg upside
18 analysts
|
— | +36.3% |
|
NGNE
Neurogene
|
Oct 01, 2021 | HOLD |
Strong Buy
+55.5% avg upside
23 analysts
|
— | -91.2% |
|
AGIO
Agios Pharma
|
Oct 01, 2021 | HOLD |
Strong Buy
+73.2% avg upside
29 analysts
|
— | -39.0% |
|
SRPT
Sarepta Therapeutics
|
Oct 01, 2021 | HOLD |
Buy
+244.5% avg upside
49 analysts
|
— | +15.1% |
|
INVA
Innoviva
|
Oct 01, 2021 | HOLD |
Buy
+27.2% avg upside
12 analysts
|
— | -31.8% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.